Dupilumab treatment is not associated with an increased overall risk of infections in patients aged 6 months to 5 years with moderate-to-severe atopic dermatitis

被引：0

作者：

Siegfried, Elaine C. ^{[1
,2
]}

Cork, Michael J. ^{[3
]}

Arkwright, Peter D. ^{[4
]}

Wollenberg, Andreas ^{[5
,6
]}

Eichenfield, Lawrence F. ^{[7
,8
]}

Ramien, Michele ^{[9
,10
]}

Khokhar, Faisal A. ^{[11
]}

Chen, Zhen ^{[11
]}

Zhang, Annie ^{[12
]}

Cyr, Sonya L. ^{[11
]}

机构：

[1] St Louis Univ, St Louis, MO USA

[2] Cardinal Glennon Childrens Hosp, St Louis, MO USA

[3] Univ Sheffield, Sheffield Dermatol Res, Sheffield, England

[4] Univ Manchester, Manchester, England

[5] Ludwig Maximilians Univ Munchen, Munich, Germany

[6] UZ Brussel, VUB, Brussels, Belgium

[7] Univ Calif San Diego, San Diego, CA USA

[8] Rady Childrens Hosp, San Diego, CA USA

[9] Alberta Childrens Prov Gen Hosp, Calgary, AB, Canada

[10] Univ Calgary, Calgary, AB, Canada

[11] Regeneron Pharmaceut Inc, Tarrytown, NY USA

[12] Sanofi, Cambridge, MA USA

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2023年 / 188卷

关键词：

atopic dermatitis; children; infections; safety; dupilumab;

D O I：

10.1093/bjd/ljac140.031

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

337

引用

页数：2

共 50 条

[31] Dupilumab treatment in moderate-to-severe atopic dermatitis: A systematic review and meta-analysis [J].

Wang, Fa-Ping ;

Tang, Xiao-Ju ;

Wei, Chuan-Qi ;

Xu, Lin-Rui ;

Mao, Hui ;

Luo, Feng-Ming .

JOURNAL OF DERMATOLOGICAL SCIENCE, 2018, 90 (02) :190-198

[32] Assessment of potential predictive factors of dupilumab response in patients with moderate-to-severe atopic dermatitis [J].

Mele-Ninot, Gemma ;

Curto-Barredo, Laia ;

Bonfill-Orti, Montserrat ;

Exposito-Serrano, Vicente ;

Munera-Campos, Monica ;

Figueras Nart, Ignasi ;

Riquelme-Mc Loughlin, Constanza ;

Gomez-Armayones, Sara ;

Spertino, Jorge ;

Serra-Baldrich, Esther .

AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2024, 65 (02) :153-162

[33] Efficacy and safety of dupilumab in patients with moderate-to-severe atopic dermatitis and comorbid allergic rhinitis [J].

Tian, Tengfei ;

Li, Yueguang ;

Yuan, Guangmei ;

Jiang, Wenxiu .

FRONTIERS IN MEDICINE, 2025, 12

[34] Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitis [J].

Berdyshev, Evgeny ;

Goleva, Elena ;

Bissonnette, Robert ;

Bronova, Irina ;

Bronoff, Anna Sofia ;

Richers, Brittany N. ;

Garcia, Shannon ;

Ramirez-Gama, Marco ;

Taylor, Patricia ;

Praestgaard, Amy ;

Agueusop, Inoncent ;

Jurvilliers, Pauline ;

Boguniewicz, Mark ;

Levit, Noah A. ;

Rossi, Ana B. ;

Zhang, Annie ;

Leung, Donald Y. M. .

ALLERGY, 2022, 77 (11) :3388-3397

[35] Switching from Dupilumab to Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Efficacy After Treatment With Dupilumab in JADE DARE [J].

Silverberg, Jonathan I. ;

Simpson, Eric L. ;

Pink, Andrew E. ;

Weidinger, Stephan ;

Chan, Gary ;

Biswas, Pinaki ;

Clibborn, Claire ;

Guler, Erman .

DERMATOLOGY AND THERAPY, 2025, 15 (02) :367-380

[36] Dupilumab Treatment in Pediatric Patients Aged 6-11 Years with Severe Atopic Dermatitis Whose Disease Is Not Adequately Controlled: A Review [J].

Cork, Michael J. ;

Danby, Simon G. ;

Rossi, Ana B. ;

Bansal, Ashish .

DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 :277-289

[37] Effect of abrocitinib and dupilumab on eosinophil levels in patients with moderate-to-severe atopic dermatitis [J].

Staumont-Salle, Delphine ;

Barbarot, Sebastien ;

Bouaziz, Jean David ;

Chan, Chan ;

Clibborn, Claire ;

Du-Thanh, Aurelie ;

Feeney, Claire ;

Lejeune, Alexandre ;

Misery, Laurent ;

Nosbaum, Audrey ;

Seneschal, Julien ;

Soria, Angele ;

Zhang, Fan .

JEADV CLINICAL PRACTICE, 2023, 2 (03) :518-530

[38] Dupilumab but not cyclosporine treatment shifts the microbiome toward a healthy skin flora in patients with moderate-to-severe atopic dermatitis [J].

Hartmann, Jan ;

Moitinho-Silva, Lucas ;

Sander, Nicole ;

Harder, Inken ;

Haesler, Robert ;

Rodriguez, Elke ;

Haufe, Eva ;

Kleinheinz, Andreas ;

Abraham, Susanne ;

Heratizadeh, Annice ;

Weisshaar, Elke ;

Schaekel, Knut ;

Handrick, Christiane ;

Augustin, Matthias ;

Wollenberg, Andreas ;

Staubach-Renz, Petra ;

Ertner, Konstantin ;

Sticherling, Michael ;

Schwarz, Beate ;

Quist, Sven ;

Wiemers, Franca ;

Schenck, Florian ;

Wildberger, Julia ;

Tittmann, Lukas ;

Lieb, Wolfgang ;

Schmitt, Jochen ;

Werfel, Thomas ;

Weidinger, Stephan .

ALLERGY, 2023, 78 (08) :2290-2300

[39] Use of Dupilumab in 543 Adult Patients With Moderate-to-Severe Atopic Dermatitis: A Multicenter, Retrospective Study [J].

Nettis, E. ;

Ferrucci, S. M. ;

Ortoncelli, M. ;

Pellacani, G. ;

Foti, C. ;

Di Leo, E. ;

Patruno, C. ;

Rongioletti, F. ;

Argenziano, G. ;

Macchia, L. ;

Tavecchio, S. ;

Napolitano, M. ;

Ribero, S. ;

Bonzano, L. ;

Romita, P. ;

Di Bona, D. ;

Nistico, S. P. ;

Piras, V ;

Calabrese, G. ;

Detoraki, C. ;

Carbonara, M. ;

Fabbrocini, G. .

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2022, 32 (02) :124-132

[40] Real-life effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis [J].

Salman, Andac ;

Sengun, Ozlem Apti ;

Aktas, Meryem ;

Taskapan, Oktay .

DERMATOLOGIC THERAPY, 2022, 35 (01)

← 1 2 3 4 5 →